세계의 흡입 일산화질소 전달 시스템 시장 : 유형, 제품, 용도, 최종 사용자별 예측(2025-2030년)

The Inhaled Nitric Oxide Delivery Systems Market was valued at USD 289.81 million in 2023, expected to reach USD 312.74 million in 2024, and is projected to grow at a CAGR of 9.65%, to USD 552.43 million by 2030.

Inhaled Nitric Oxide (iNO) Delivery Systems are critical in treating patients with respiratory complications, primarily due to their vasodilatory effects which enhance oxygenation and help manage conditions such as Persistent Pulmonary Hypertension of the Newborn (PPHN) and Acute Respiratory Distress Syndrome (ARDS). The necessity of these systems stems from their non-invasive approach in delivering targeted nitric oxide therapy, minimizing systemic side effects while enhancing pulmonary function. End-use sectors primarily include hospitals, specialized clinics, and homecare settings, with applications spanning neonatal, pediatric, and adult patient care units. Market growth is primarily driven by an increasing prevalence of respiratory conditions, technological advancements in delivery systems, and a growing demand for non-invasive therapeutic options. Additionally, expanding healthcare infrastructure in emerging markets and heightened awareness about respiratory interventions further catalyze market expansion.

The latest potential opportunities in this market rest in the development of portable and cost-effective iNO systems, increased penetration into emerging markets, and integration with telehealth platforms to facilitate remote monitoring and administration. However, market growth faces limitations from stringent regulatory landscapes, high treatment costs, and the complexity involved in precise dosing and administration. Moreover, reliance on established manufacturers restricts the entry of smaller, innovative players. To circumvent these challenges, firms should focus on innovation in device portability, enhancing patient compliance, and collaborations with regulatory bodies for smoother approval processes. Research and innovation areas include smart delivery systems that monitor real-time patient response and cloud-based data analytics for personalized treatment protocols. Overall, while the inhaled nitric oxide delivery systems market is poised for growth, stakeholders must navigate regulatory and cost challenges to fully exploit the promising opportunities ahead.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Inhaled Nitric Oxide Delivery Systems Market

The Inhaled Nitric Oxide Delivery Systems Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising incidents of respiratory disorders
  • Rising need for delivery systems due to improved adoption of inhaled nitric oxide
• Market Restraints
  • High cost and product recall with inhaled nitric oxide delivery systems
• Market Opportunities
  • Growth in the inhaled nitric oxide delivery systems for mechanically ventilated and nonintubated patients
• Market Challenges
  • Functional limitation with inhaled nitric oxide delivery systems

Porter's Five Forces: A Strategic Tool for Navigating the Inhaled Nitric Oxide Delivery Systems Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Inhaled Nitric Oxide Delivery Systems Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Inhaled Nitric Oxide Delivery Systems Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Inhaled Nitric Oxide Delivery Systems Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Inhaled Nitric Oxide Delivery Systems Market

A detailed market share analysis in the Inhaled Nitric Oxide Delivery Systems Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Inhaled Nitric Oxide Delivery Systems Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Inhaled Nitric Oxide Delivery Systems Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Inhaled Nitric Oxide Delivery Systems Market

A strategic analysis of the Inhaled Nitric Oxide Delivery Systems Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Inhaled Nitric Oxide Delivery Systems Market, highlighting leading vendors and their innovative profiles. These include Air Liquide Inc., Bellerophon Therapeutics Inc., Beyond Air Inc., Getinge AB, International Biomedical Ltd., Linde PLC, Mallinckrodt PLC, Niox by Circassia Pharmaceuticals, Nu-Med Labs, SLE Ltd., and Vero Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Inhaled Nitric Oxide Delivery Systems Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Type, market is studied across Adult and Pediatrics.
• Based on Product, market is studied across Disposables and System.
• Based on Application, market is studied across Acute Hypoxemic Respiratory Failure and Hypoxic Respiratory Failure.
• Based on End-user, market is studied across Ambulatory Centers, Clinics, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising incidents of respiratory disorders
    • 5.1.1.2. Rising need for delivery systems due to improved adoption of inhaled nitric oxide
  • 5.1.2. Restraints
    • 5.1.2.1. High cost and product recall with inhaled nitric oxide delivery systems
  • 5.1.3. Opportunities
    • 5.1.3.1. Growth in the inhaled nitric oxide delivery systems for mechanically ventilated and nonintubated patients
  • 5.1.4. Challenges
    • 5.1.4.1. Functional limitation with inhaled nitric oxide delivery systems
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Inhaled Nitric Oxide Delivery Systems Market, by Type

• 6.1. Introduction
• 6.2. Adult
• 6.3. Pediatrics

7. Inhaled Nitric Oxide Delivery Systems Market, by Product

• 7.1. Introduction
• 7.2. Disposables
• 7.3. System

8. Inhaled Nitric Oxide Delivery Systems Market, by Application

• 8.1. Introduction
• 8.2. Acute Hypoxemic Respiratory Failure
• 8.3. Hypoxic Respiratory Failure

9. Inhaled Nitric Oxide Delivery Systems Market, by End-user

• 9.1. Introduction
• 9.2. Ambulatory Centers
• 9.3. Clinics
• 9.4. Hospitals

10. Americas Inhaled Nitric Oxide Delivery Systems Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Inhaled Nitric Oxide Delivery Systems Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Inhaled Nitric Oxide Delivery Systems Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Air Liquide Inc.
• 2. Bellerophon Therapeutics Inc.
• 3. Beyond Air Inc.
• 4. Getinge AB
• 5. International Biomedical Ltd.
• 6. Linde PLC
• 7. Mallinckrodt PLC
• 8. Niox by Circassia Pharmaceuticals
• 9. Nu-Med Labs
• 10. SLE Ltd.
• 11. Vero Biotech Inc.